⌘+K

Latest share price

SEK

24.5

-2.59%

20 Nov 2026 17:29 CET

Fair value range

SEK

33.0

—

44.0

24 Jun 2026

Market cap

SEK

1,732

m

Next report

Q4

4 Feb 2027

Carasent

Healthcare

2026-10-16

Q3 a hint of the profitability potential- Q3 review

Q3 was strong with the main highlight being the adj. EBITDAC margin at 19.8% in the quarter. Although development in Q4 will likely be impeded by seasonally lower...

Post-Results Note

Kristofer Liljeberg

Elvin Rolder

Q3 a hint of the profitability potential- Q3 review

Strong Q3 should validate the margin story - initial comment

Margin expansion on course - Q3 preview

Carasent

Healthcare

2026-10-15

Strong Q3 should validate the margin story - initial comment

Overall impression. A strong Q3 report from Carasent, with a 20% adj. EBITAC margin, up 5%-points Y/Y. Revenue reached SEK108m, 2% above our forecast as both recurring...

News

Kristofer Liljeberg

Elvin Rolder

Q3 a hint of the profitability potential- Q3 review

Strong Q3 should validate the margin story - initial comment

Margin expansion on course - Q3 preview

Carasent

Healthcare

2026-09-29

Margin expansion on course - Q3 preview

We expect a strong quarter from Carasent, with robust organic recurring revenue growth Y/Y, and continued improvements in profitability, both organically and in the...

Pre-Results Note

Kristofer Liljeberg

Elvin Rolder

Q3 a hint of the profitability potential- Q3 review

Strong Q3 should validate the margin story - initial comment

Margin expansion on course - Q3 preview

Price chart

Price

Fair range high value

Fair range low value

Year

2024

2025

2026e

2027e

2028e

EPS

-0.58

0.48

0.39

0.88

1.23

EPS (Adj.)

-0.02

0.31

0.62

1.01

1.34

Sales Growth

12.40%

24.91%

20.48%

21.43%

14.00%

EPS Growth (Adj.)

22.65%

143.51%

99.37%

64.33%

31.99%

P/E

51.0

62.5

27.8

19.9

P/E (Adj.)

79.1

39.7

24.1

18.3

EV/EBITA

-32.6

87.5

51.1

18.0

12.8

EV/EBITDA

131.2

22.3

18.8

10.7

8.2

Learn more

Key facts

Sector

Healthcare

Country

Sweden

Tickers

CARA@SS, CARA.ST

CEO

Daniel Öhman

CFO

Svein Martin Bjørnstad

About DNB Carnegie Access

DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.

Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.

Private Banking

Tailored wealth management. Your financial future, personalized.

Montrose

A digital investment platform designed for passionate investors.

DNB Carnegie

Leading Nordic investment bank and wealth management.

© Copyright DNB Carnegie Investment Bank AB